Skip to content

Allan V Kalueff

4 papers in the library · 138 citations · publishing 2013-2024

Papers

Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research.

Behavioural brain research January 1, 2013 Jonathan Cachat, Evan J Kyzar, Christopher Collins et al. 112 citations

Ibogaine, a psychoactive compound from the iboga plant, alters multiple behaviors in adult zebrafish. At doses of 10 and 20 mg/L, it reversed the natural diving response, causing initial top swimming followed by bottom dwelling, and reduced the innate preference for dark environments. It did not change overall locomotion or wall-hugging behavior but altered spatial exploration, promoted mirror interaction, disrupted group cohesion, and induced color changes from melanophore aggregation. Brain c-fos expression and whole-body cortisol levels remained unchanged. These results demonstrate ibogaine's complex pharmacological profile and support the use of zebrafish for studying hallucinogenic drug effects.

Anxiolytic-like effects of noribogaine in zebrafish.

Behavioural brain research July 14, 2017 Allan V Kalueff, Aleksandra Kaluyeva, Emeline L Maillet 21 citations

Noribogaine, the main psychoactive metabolite of ibogaine, produces robust anxiolytic-like behavior in adult zebrafish without affecting locomotion. In a 5-minute novel tank test following acute 20-minute immersion in 1, 5, or 10 mg/L noribogaine, treated fish spent more time and made more transitions to the top half compartment and showed fewer freezing bouts compared to controls. These results indicate noribogaine modulates components of the acute stress response related to emotionality and anxiety, suggesting it may be a potentially useful non-sedative anxiolytic agent.

Ketamine modulates the exploratory dynamics and homebase-related behaviors of adult zebrafish.

Pharmacology, biochemistry, and behavior December 1, 2024 Camilla W Pretzel, João V Borba, Cássio M Resmim et al. 5 citations

Acute exposure to subanesthetic doses of ketamine (20 and 40 mg/L) increased total distance traveled in adult zebrafish, indicating hyperlocomotion. All tested concentrations (2, 20, and 40 mg/L) elicited circling behavior, a stereotyped-like response that diminished over time. Ketamine also reduced thigmotaxis and homebase activity while increasing the average length of trips, suggesting anxiolytic-like effects on spatio-temporal exploratory dynamics. These findings support ketamine's modulatory influence on behavior and highlight homebase-related measurements as useful for assessing behavioral changes in zebrafish models.

Effects of a non-competitive N-methyl-d-aspartate (NMDA) antagonist, tiletamine, in adult zebrafish.

Neurotoxicology and teratology January 1, 2017 Tatiana O Kolesnikova, Sergey L Khatsko, Vadim A Shevyrin et al.

Tiletamine, a veterinary anesthetic related to ketamine, produces dose-dependent sedative effects in adult zebrafish. Immersion in 1 mg/L caused only reduced top entries in a novel tank test, while 5 and 10 mg/L caused robust sedation and skin darkening. Brain samples confirmed tiletamine presence only at the two higher doses. The results demonstrate potent neurotropic effects of tiletamine in zebrafish and support the use of fish-based aquatic screens for studying NMDA receptor antagonists.